[Langerhans cell histiocytosis: Skin diseases and visceral lesions].

Autor:	Elkin VD; Acad. E.A. Vagner Perm State Medical Academy, Ministry of Health of Russia, Perm, Russia., Sedova TG; Acad. E.A. Vagner Perm State Medical Academy, Ministry of Health of Russia, Perm, Russia., Kopytova EA; Acad. E.A. Vagner Perm State Medical Academy, Ministry of Health of Russia, Perm, Russia., Plotnikova EV; Acad. E.A. Vagner Perm State Medical Academy, Ministry of Health of Russia, Perm, Russia.
Jazyk:	ruština
Zdroj:	Terapevticheskii arkhiv [Ter Arkh] 2017; Vol. 89 (4), pp. 115-120.
DOI:	10.17116/terarkh2017894115-120
Abstrakt:	Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disorder that belongs to class I histiocytoses and is characterized by infiltration of one or many organs by Langerhans cells to form granulomas. The literature analysis could identify a lot of etiological, pathogenetic, and trigger factors and mechanisms for LCH development, which determine the diversity of the clinical picture and course of the disease. The clinical manifestations of LCH are very variable and depend on the severity of lesions and the age of patients. In addition to skin lesions, there is involvement of one or more visceral organs. Difficulties in diagnosing the disease lead to statistical variations of LCH in different countries of the world and require more attention by physicians of all specialties.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu